Emergence of Daptomycin-Resistant Staphylococcus aureus during Treatment

Published on Jan 1, 2016in Internal Medicine1.005
· DOI :10.2169/INTERNALMEDICINE.55.4763
Hideharu Hagiya3
Estimated H-index: 3
(Okayama University),
Yuto Haruki5
Estimated H-index: 5
+ 6 AuthorsFumio Otsuka35
Estimated H-index: 35
(Okayama University)
Abstract A 68-year-old man with persistent bacteremia accompanying a large iliopsoas abscess, vertebral osteomyelitis, discitis and central venous port infection caused by methicillin-resistant Staphylococcus aureus (MRSA) was admitted to our hospital. During the course of treatment, the emergence of a daptomycin (DAP)-resistant MRSA strain was confirmed; the minimum inhibitory concentration was 1 to 2 μg/mL for vancomycin and more than 1 μg/mL for DAP. Although the bacterial cell wall was not significantly thickened, an increased positive surface charge and single-nucleotide polymorphism within mprF have been confirmed in DAP-resistant strains. Still rare, but clinicians need to be cautious of the emergence of DAP-resistant MRSA during treatment.
#1Nagendra N. Mishra (UCLA: University of California, Los Angeles)H-Index: 26
#2Arnold S. Bayer (UCLA: University of California, Los Angeles)H-Index: 96
Last. Soo-Jin Yang (UCLA: University of California, Los Angeles)H-Index: 21
view all 11 authors...
Development of in vivo daptomycin resistance (DAP-R) among Staphylococcus aureus clinical isolates, in association with clinical treatment failures, has become a major therapeutic problem. This issue is especially relevant to methicillin-resistant S. aureus (MRSA) strains in the context of invasive endovascular infections. In the current study, we used three well-characterized and clinically-derived DAP-susceptible (DAP-S) vs. resistant (DAP-R) MRSA strain-pairs to elucidate potential genotypic ...
72 CitationsSource
#1April M. Bobenchik (UCLA: University of California, Los Angeles)H-Index: 10
#2Janet A. Hindler (UCLA Health)H-Index: 5
Last. Romney M. Humphries (UCLA: University of California, Los Angeles)H-Index: 41
view all 5 authors...
Vitek 2 (bioMerieux, Inc., Durham, NC) is a widely used commercial antimicrobial susceptibility testing system. We compared MIC results obtained by Vitek 2 to those obtained by the Clinical and Laboratory Standards Institute (CLSI) broth microdilution (BMD) reference method for 134 staphylococcal and 84 enterococcal clinical isolates. Nineteen agents were evaluated, including all those available on Vitek 2 for testing staphylococci and enterococci. The resistance phenotypes tested included methi...
33 CitationsSource
#1Oriol GaschH-Index: 18
#2Mariana CamoezH-Index: 11
Last. Nieves LarrosaH-Index: 17
view all 60 authors...
42 CitationsSource
#1Romney M. Humphries (UCLA: University of California, Los Angeles)H-Index: 41
#2Simon Pollett (USYD: University of Sydney)H-Index: 14
Last. George Sakoulas (UCSD: University of California, San Diego)H-Index: 63
view all 3 authors...
SUMMARY Daptomycin is a lipopeptide antimicrobial with in vitro bactericidal activity against Gram-positive bacteria that was first approved for clinical use in 2004 in the United States. Since this time, significant data have emerged regarding the use of daptomycin for the treatment of serious infections, such as bacteremia and endocarditis, caused by Gram-positive pathogens. However, there are also increasing reports of daptomycin nonsusceptibility, in Staphylococcus aureus and, in particular,...
144 CitationsSource
#1Ute Bertsche (University of Tübingen)H-Index: 12
#2Soo-Jin Yang (UCLA: University of California, Los Angeles)H-Index: 21
Last. Christopher Weidenmaier (University of Tübingen)H-Index: 28
view all 12 authors...
Multiple mechanisms have been correlated with daptomycin-resistance (DAP-R) in Staphylococcus aureus. However, one common phenotype observed in many DAP-R S. Aureus strains is a thickened cell wall (CW). The first evidence for an impact of CW-linked glycopolymers on this phenotype was recently demonstrated in a single, well-characterized DAP-R methicillin-susceptible S. aureus (MSSA) strain. In this isolate the thickened CW phenotype was linked to an increased production and D-alanylation of wal...
59 CitationsSource
#1Arnold S. Bayer (UCLA: University of California, Los Angeles)H-Index: 96
#2Tanja Schneider (University of Bonn)H-Index: 32
Last. Hans-Georg Sahl (University of Bonn)H-Index: 85
view all 3 authors...
The bactericidal, cell membrane-targeting lipopeptide antibiotic daptomycin (DAP) is an important agent in treating invasive Staphylococcus aureus infections. However, there have been numerous recent reports of development of daptomycin-resistance (DAP-R) during therapy with this agent. The mechanisms of DAP-R in S. aureus appear to be quite diverse. DAP-R strains often exhibit progressive accumulation of single nucleotide polymorphisms in the multipeptide resistance factor gene (mprF) and the y...
208 CitationsSource
#1Tadashi Maeda (Toho University)H-Index: 6
#2Tomoo Saga (Toho University)H-Index: 15
Last. Kazuhiro Tateda (Toho University)H-Index: 35
view all 13 authors...
We aimed to elucidate the current epidemiological features of outpatient skin and soft tissue infection (SSTI)-associated methicillin-resistant Staphylococcus aureus (MRSA) in Japan. Altogether, we evaluated the performance of a phage-open reading frame typing (POT) kit for genotyping these MRSA strains. We collected 57 MRSA strains from all outpatients with SSTIs attending a teaching hospital in Japan. Drug susceptibility measurement and genotyping including SCCmec typing, spa typing, multilocu...
16 CitationsSource
#1Sebastian Van Hal (University of Western Sydney)H-Index: 15
#2Slade O. Jensen (University of Western Sydney)H-Index: 24
Last. Iain B Gosbell (University of Western Sydney)H-Index: 28
view all 6 authors...
Summary: Staphylococcus aureus bacteremia (SAB) is an important infection with an incidence rate ranging from 20 to 50 cases/100,000 population per year. Between 10% and 30% of these patients will die from SAB. Comparatively, this accounts for a greater number of deaths than for AIDS, tuberculosis, and viral hepatitis combined. Multiple factors influence outcomes for SAB patients. The most consistent predictor of mortality is age, with older patients being twice as likely to die. Except for the ...
471 CitationsSource
#1Anton Y. Peleg (Monash University)H-Index: 58
#2Spiros Miyakis (Harvard University)H-Index: 20
Last. George M. Eliopoulos (Harvard University)H-Index: 79
view all 9 authors...
Background: Daptomycin remains one of our last-line anti-staphylococcal agents. This study aims to characterize the genetic evolution to daptomycin resistance in S. aureus. Methods: Whole genome sequencing was performed on a unique collection of isogenic, clinical (21 strains) and laboratory (12 strains) derived strains that had been exposed to daptomycin and developed daptomycin-nonsusceptibility. Electron microscopy (EM) and lipid membrane studies were performed on selected isolates. Results: ...
161 CitationsSource
#1S. J. van HalH-Index: 23
#2David L. Paterson (UQ: University of Queensland)H-Index: 128
Last. Iain B Gosbell (University of Western Sydney)H-Index: 28
view all 3 authors...
A patient developed a daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) infection, despite being daptomycin-naive, in the setting of persistent bacteraemia secondary to vertebral osteomyelitis. Modified population analysis profiling of sequential MRSA blood culture isolates revealed transition from a vancomycin-susceptible phenotype to a vancomycin-intermediate S. aureus (VISA) phenotype through a vancomycin-heteroresistant S. aureus (hVISA) intermediary. Increased cell wal...
105 CitationsSource
Cited By2
#1Christoph FleegeH-Index: 3
#2Michael RauschmannH-Index: 14
Last. Thomas A. WichelhausH-Index: 32
view all 3 authors...
Fur eine erfolgreiche Behandlung der pyogenen Spondylodiszitis ist eine suffiziente Antibiotikatherapie essenziell. Bei hamodynamisch stabilen Patienten mit normalem neurologischem Status sollte mit einer Antibiotikatherapie solange gewartet werden, bis die mikrobiologische Diagnostik einen Erregernachweis mit Antibiogramm erbringt und somit eine gezielte Therapie ermoglicht. Bei hamodynamisch instabilen Patienten oder bei Patienten mit fortschreitenden bzw. schweren neurologischen Symptomen sol...